[Summary] 生物医药研发商
迪哲医药（股票代码：688192）是一家创新型生物医药企业，专注于恶性肿瘤、免疫性疾病领域创新疗法的研究、开发和商业化。公司坚持源头创新的研发理念，以推出全球首创药物（First-in-）和具有突破性潜力的治疗方法为目标，旨在填补全球未被满足的临床需求。基于*的转化科学和新药分子设计与筛选技术平台，公司已建立了五款具备全球竞争力的产品管线，两大领先产品处于全球关键性临床试验阶段，其中一款已获批上市。
Dizal Pharmaceutical Co., Ltd (Ticker: 688192 ) is a commercial stage biopharmaceutical company. At Dizal we aspire to discover develop differentiated therapeutics fthe treatment of cancer immunological diseases. Building on our extensive expertise in translational science molecular design, we have established an internationally competitive portfolio of five clinical-stage assets with two leading assets in global pivotal studies one already approved.
What does 迪哲（江苏）医药股份有限公司 require? Who is 迪哲医药 hiring? 迪哲医药招聘类别销售类占比最多占64.1%，其次是医疗卫生/美容保健类占28.7%。迪哲医药什么学历能进？本科占比最多占58.6%，其次是大专占31.9%。迪哲医药学历要求高吗？硕士占3.2%。工作经验迪哲医药有什么要求？不限占比最多占39%，其次是1-3年占35.1%。迪哲医药工作地区在哪？上海占比最多占22.3%，其次是无锡占10.8%。 Based on job postings from the past year, for reference only.
Provided by
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows
Jobui does not provide an APP. Please follow our WeChat official account.
